ASSESSING THE SAFETY AND EFFECTIVENESS OF INTERMITTENT FASTING FOR GLYCEMIC CONTROL AND CARDIOVASCULAR HEALTH IN TYPE 2 DIABETES: A LONG-TERM META-ANALYSIS.
Main Article Content
Keywords
Intermittent fasting, type 2 diabetes, glycemic control, cardiovascular risk factors
Abstract
Background
Type 2 diabetes (T2D) is a prevalent metabolic disorder linked to insulin resistance and chronic hyperglycemia. Despite available treatment options, managing glycemic control and preventing cardiovascular complications remain a challenge. Intermittent fasting (IF), which involves alternating periods of eating and fasting, has been proposed as a potential intervention for improving metabolic health in individuals with T2D. This meta-analysis evaluates the effects of IF on glycemic control, cardiovascular risk factors, and overall metabolic health in T2D patients.
Methods
A systematic review and meta-analysis were conducted using data from randomized controlled trials (RCTs) and observational studies, accessed via PubMed, Scopus, Web of Science, PsycINFO, and the Cochrane Library. Inclusion criteria consisted of studies examining IF interventions in adults with T2D, measuring outcomes such as HbA1c, fasting glucose, insulin sensitivity, weight, lipid profiles, and blood pressure. Statistical analysis was performed using a random-effects model to compute standardized mean differences (SMDs) and assess heterogeneity.
Results
A total of 10 RCTs, involving 2,051 participants, were included in the analysis. IF was associated with significant improvements in glycemic control, with HbA1c levels decreasing by an average of 0.9% (p < 0.05) and fasting glucose reduced by 24 mg/dL. Weight loss (3.0–5.0 kg) and improvements in lipid profiles, including reductions in LDL cholesterol (10–15 mg/dL) and triglycerides (12–20 mg/dL), were observed. Additionally, systolic and diastolic blood pressure decreased by 5–7 mmHg and 3–5 mmHg, respectively. The safety profile showed mild hypoglycemia in 7–12% of participants, with few adverse events overall. Adherence rates were high, ranging from 85% to 96%.
Conclusions
This meta-analysis suggests that intermittent fasting provides significant metabolic benefits, improving glycemic control, weight loss, and cardiovascular risk factors in individuals with T2D. The 5:2 and time-restricted eating protocols appeared most effective. While IF is a promising adjunctive treatment, further research on long-term effects and individualized fasting protocols is necessary to optimize outcomes.
References
2. Sharma, S. K., Mudgal, S. K., Kalra, S., Gaur, R., Thakur, K., & Agarwal, R. (2023). Effect of intermittent fasting on glycaemic control in patients with Type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials. touchREVIEWS in Endocrinology, 19(1), 25. https://doi.org/10.17925/ee.2023.19.1.25
3. Tinsley, G. M., & La Bounty, P. M. (2015). Effects of intermittent fasting on body composition and clinical health markers in humans. Nutrition Reviews, 73(10), 661–674. https://doi.org/10.1093/nutrit/nuv041
4. Obermayer, A., Tripolt, N. J., Pferschy, P. N., Kojzar, H., Aziz, F., Müller, A., Schauer, M., Oulhaj, A., Aberer, F., Sourij, C., Habisch, H., Madl, T., Pieber, T., Obermayer-Pietsch, B., Stadlbauer, V., & Sourij, H. (2022). Efficacy and safety of intermittent fasting in people with Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A randomized controlled trial. Diabetes Care, 46(2), 463–468. https://doi.org/10.2337/dc22-1622
5. Guo, L., Xi, Y., Jin, W., Yuan, H., Qin, G., Chen, S., Zhang, L., Liu, Y., Cheng, X., Liu, W., & Yu, D. (2024). A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes. JAMA Network Open, 7(6), e2416786. https://doi.org/10.1001/jamanetworkopen.2024.16786
6. Corley, B. T., Carroll, R. W., Hall, R. M., Weatherall, M., Parry‐Strong, A., & Krebs, J. D. (2018). Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabetic Medicine, 35(5), 588–594. https://doi.org/10.1111/dme.13595
7. Yang, X., Zhou, J., Shao, H., Huang, B., Kang, X., Wu, R., Bian, F., Hu, M., & Liu, D. (2022). Effect of an intermittent calorie-restricted diet on Type 2 diabetes remission: a randomized controlled trial. The Journal of Clinical Endocrinology & Metabolism, 108(6), 1415–1424. https://doi.org/10.1210/clinem/dgac661
8. Teong, X. T., Liu, K., Vincent, A. D., Bensalem, J., Liu, B., Hattersley, K. J., Zhao, L., Feinle-Bisset, C., Sargeant, T. J., Wittert, G. A., Hutchison, A. T., & Heilbronn, L. K. (2023). Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes: a randomized controlled trial. Nature Medicine, 29(4), 963–972. https://doi.org/10.1038/s41591-023-02287-7
9. Pavlou, V., Cienfuegos, S., Lin, S., Ezpeleta, M., Ready, K., Corapi, S., Wu, J., Lopez, J., Gabel, K., Tussing-Humphreys, L., Oddo, V. M., Alexandria, S. J., Sanchez, J., Unterman, T., Chow, L. S., Vidmar, A. P., & Varady, K. A. (2023). Effect of Time-Restricted eating on weight loss in adults with Type 2 diabetes. JAMA Network Open, 6(10), e2339337. https://doi.org/10.1001/jamanetworkopen.2023.39337
10. Society, E. (2023, January 18). Intermittent fasting may reverse type 2 diabetes. Endocrine Society. https://www.endocrine.org/news-and-advocacy/news-room/2022/intermittent-fasting-may-reverse-type-2-diabetes#:~:text=After%20an%20intermittent%20fasting%20diet,Society%27s%20Journal%20of%20Clinical%20Endocrinology%20%26
11. Xiaoyu, W., Yuxin, X., & Li, L. (2024). The effects of different intermittent fasting regimens in people with type 2 diabetes: a network meta-analysis. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1325894
12. News-Medical. (2024, June 24). Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes. https://www.news-medical.net/news/20240624/Intermittent-fasting-outperforms-traditional-drugs-in-managing-early-type-2-diabetes.aspx#:~:text=Intermittent%20fasting%20outperforms%20traditional%20drugs%20in%20managing%20early%20type%202%20diabetes,-Download%20PDF%20Copy&text=A%20randomized%20clinical%20trial%20has,in%20controlling%20blood%20glucose%20levels.
13. Vasquez, I. (2024, October 4). What is intermittent fasting? Types and risks explained. Popsugar. https://www.popsugar.com/nutrition/what-intermittent-fasting-43275575
14. Harvie, M. N., Pegington, M., Mattson, M. P., Frystyk, J., Dillon, B., Evans, G., Cuzick, J., Jebb, S. A., Martin, B., Cutler, R. G., Son, T. G., Maudsley, S., Carlson, O. D., Egan, J. M., Flyvbjerg, A., & Howell, A. (2010). The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. International Journal of Obesity, 35(5), 714–727. https://doi.org/10.1038/ijo.2010.171
15. Guo, L., Xi, Y., Jin, W., Yuan, H., Qin, G., Chen, S., Zhang, L., Liu, Y., Cheng, X., Liu, W., & Yu, D. (2024b). A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes. JAMA Network Open, 7(6), e2416786. https://doi.org/10.1001/jamanetworkopen.2024.16786
16. Cienfuegos, S., Gabel, K., Kalam, F., Ezpeleta, M., Wiseman, E., Pavlou, V., Lin, S., Oliveira, M. L., & Varady, K. A. (2020). Effects of 4- and 6-h Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults with Obesity. Cell Metabolism, 32(3), 366-378.e3. https://doi.org/10.1016/j.cmet.2020.06.018
17. Patterson, R. E., Laughlin, G. A., LaCroix, A. Z., Hartman, S. J., Natarajan, L., Senger, C. M., Martínez, M. E., Villaseñor, A., Sears, D. D., Marinac, C. R., & Gallo, L. C. (2015). Intermittent fasting and human metabolic health. Journal of the Academy of Nutrition and Dietetics, 115(8), 1203–1212. https://doi.org/10.1016/j.jand.2015.02.018
18. Corley, B. T., Carroll, R. W., Hall, R. M., Weatherall, M., Parry‐Strong, A., & Krebs, J. D. (2018b). Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabetic Medicine, 35(5), 588–594. https://doi.org/10.1111/dme.13595
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Tahreem Mukhtar
Rashid Latif Medical College, Lahore, Pakistan
Dr. Kainaat Javed
Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), PIMS, Islamabad, Pakistan
Sania Khalid
CMH Institute of Medical Sciences, Bahawalpur, Pakistan
Sonam Lohana
Liaquat university of medical and health sciences
Zain Ul Abideen
MBBS, Quaid-e-Azam Medical College, Bahawalpur, Pakistan
Abdul Mateen Soomro
Ziaudin college of public health, Karachi, Pakistan
Sohaib Raza
Sharif Medical and Dental College Lahore, Pakistan,